SERODUS AS

City:

Oslo

Country:

Norway

Published Applications:

Last publication date:

2023-12-28

Patent Grants:

Last grant date:

2024-09-10

Top Inventors for applications by SERODUS AS

These are the the leading inventors for applications assigned to SERODUS AS:

SERODUS AS based in Oslo, NO has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

Dual TNFR1 antagonists and TNER2 agonists for use in renal diseases

5-HT RECEPTOR MODULATING COMPOUNDS

5-HT4 receptor antagonists for the treatment of heart failure

Modulators of peripheral 5-HT receptors

Also check out SERODUS AS's (Oslo, Norway) applicant profile with 1 patent applications submitted.

AssigneeID:

180632 ⎘